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        The recruitment of neutrophils into infl  amed 
tissue is an important immunological process 
that proceeds along a well-defi  ned cascade of 
events beginning with the capture of neutro-
phils to the infl  amed endothelium and followed 
by neutrophil rolling along the endothelium (  1  ). 
Both capture and rolling are mediated by se-
lectins binding to selectin ligands (  2  ). During 
rolling, neutrophils are in intimate contact with 
the infl  amed endothelium, enabling endothelial-
bound chemokines to interact with specifi  c che-
mokine receptors expressed on the surface of 
neutrophils. This in turn triggers the activation 
of       2   integrins, which eventually leads to fi  rm 
neutrophil arrest (  3  ). The CXC chemokine 
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    Recent in vitro studies have suggested a role for sialylation in chemokine receptor binding to 
its ligand (Bannert, N., S. Craig, M. Farzan, D. Sogah, N.V. Santo, H. Choe, and J. Sodroski. 
2001.   J. Exp. Med.   194:1661  –  1673). This prompted us to investigate chemokine-induced 
leukocyte adhesion in infl  amed cremaster muscle venules of     2,3 sialyltransferase (ST3Gal-IV)-
defi  cient mice. We found a marked reduction in leukocyte adhesion to infl  amed microvessels 
upon injection of the CXCR2 ligands CXCL1 (keratinocyte-derived chemokine) or CXCL8 
(interleukin 8). In addition, extravasation of ST3Gal-IV      /      neutrophils into thioglycollate-
pretreated peritoneal cavities was signifi  cantly decreased. In vitro assays revealed that CXCL8 
binding to isolated ST3Gal-IV      /      neutrophils was markedly impaired. Furthermore, CXCL1-
mediated adhesion of ST3Gal-IV      /      leukocytes at physiological fl  ow conditions, as well as 
transendothelial migration of ST3Gal-IV      /      leukocytes in response to CXCL1, was signifi  cantly 
reduced. In human neutrophils, enzymatic desialylation decreased binding of CXCR2 ligands to 
the neutrophil surface and diminished neutrophil degranulation in response to these chemo-
kines. In addition, binding of     2,3-linked sialic acid  –  specifi  c   Maackia amurensis   lectin II to 
purifi  ed CXCR2 from neuraminidase-treated CXCR2-transfected HEK293 cells was markedly 
impaired. Collectively, we provide substantial evidence that sialylation by ST3Gal-IV signifi  -
cantly contributes to CXCR2-mediated leukocyte adhesion during infl  ammation in vivo. 1436 ST3  GAL  -IV CONTROLS LEUKOCYTE ADHESION   | Frommhold et al. 
these fi  ndings point toward an important role of glycosylation 
and sialylation in the function of some chemokine receptors, 
the contribution of distinct glycosyltransferases in the proper 
synthesis of carbohydrate structures crucial for chemokine re-
ceptor function has not been investigated. Recently, mice de-
fi  cient in the     2,3 sialyltransferase (ST3Gal-IV) have been 
generated (  11  ). In vivo studies on P-, E-, and     L  -  selectin  –
  mediated leukocyte rolling in infl  amed cremaster muscle 
venules of ST3Gal-IV      /      mice revealed a complete absence 
of L-selectin ligand function and a partial impairment in E-
selectin  –  dependent leukocyte rolling, whereas P-selectin  –
  dependent rolling was not aff  ected (  12, 13  ). 
  In this study, we will present substantial evidence that leu-
kocyte adhesion and extravasation are impaired in ST3Gal-
IV      /      mice. Because of the rather mild defect at the level of 
leukocyte rolling, the impairment in leukocyte adhesion and 
extravasation in ST3Gal-IV      /      mice cannot be explained by 
the observed rolling defect. We therefore hypothesized that 
sialylation by ST3Gal-IV contributes to chemokine-triggered 
neutrophil arrest in vivo. To this end, we investigated leuko-
cyte arrest mechanisms in unstimulated and TNF-      –  stimulated 
cremaster muscle venules of ST3Gal-IV      /      mice in vivo and 
in various static and dynamic assays in vitro. 
    RESULTS   
  Leukocyte adhesion in trauma-induced infl  ammation 
  Leukocyte adhesion was assessed in 58 cremaster muscle 
venules of 13 ST3Gal-IV      /      mice and compared with leu-
kocyte adhesion in 37 venules of 13 WT control mice. 
Hemodynamic parameters between the groups showed no 
signifi  cant diff  erence in vascular diameter, blood fl  ow ve-
locity, wall shear rate, and systemic white blood cell (WBC) 
count (  Table I  ). Leukocyte adhesion in postcapillary venules of 
the cremaster muscle during the fi  rst hour after exteriorization 
CXCL8 has been demonstrated to induce human neutrophil 
arrest from neutrophil rolling in a dynamic in vitro assay (  4  ). 
Using intravital microscopy, a subsequent report demon-
strated that triggering of neutrophil arrest in unstimulated 
mouse cremaster muscle venules was almost completely de-
pendent on CXCR2-mediated events (  5  ). In contrast, stimu-
lating the cremaster muscle by intrascrotal injection of TNF-    
led to neutrophil arrest, which was not strictly dependent on 
CXCR2 but occurred in an overlapping fashion with an E-
selectin  –  mediated mechanism (  5  ). 
  During leukocyte recruitment, an essential role of post-
translational glycosylation has been identifi  ed for selectin li-
gand function. This became particularly apparent in mice with 
a genetic deletion in glycosyltransferases such as fucosyltrans-
ferase VII or core 2 GlcNAcT-I (  6, 7  ). Both enzymes are crit-
ically involved in the synthesis of core 2  –  decorated O-glycans 
carrying the selectin binding motif sialyl Lewis X as a capping 
group. Deletion of these enzymes led to a profound impair-
ment of selectin-dependent leukocyte rolling in vivo (  6, 8  ). 
Recently, it has been demonstrated that posttranslational gly-
cosylation also infl  uences the function of chemokine recep-
tors (  9, 10  ). Ludwig et al. demonstrated that   N  -glycosylation 
of human CXCR2 protects this receptor from proteolytic 
degradation and removal from the surface of neutrophils, 
whereas it does not interfere with its traffi   cking function (  9  ). 
Bannert et al. used a canine thymocyte cell line to generate 
cells stably expressing WT CCR5 and CCR5 mutants. In 
CCR5 mutants, serine or threonine residues were changed to 
alanine at putative O-glycosylation sites at the N terminus of 
CCR5 (  10  ). Functional analysis of the cell lines carrying the 
diff  erent CCR5 mutants revealed that CCR5 binding to the 
CC chemokines macrophage infl  ammatory proteins 1     and 
1     was strongly dependent on a sialic acid carrying O-glycan 
linked to serine 6 at the N terminus of CCR5 (  10  ). Although 
    Table I.        Hemodynamic parameters (mean   ±   SEM of diameter, centerline velocity, shear rate, and WBC) of cremaster muscle 
venules in ST3Gal-IV     /   ,  CXCR2 bm   /    , and WT control mice 
Mice Venules Diameter Blood fl  ow velocity Shear rate WBC
  (n)   (n)   ( μ m)   ( μ m/s)   (1/s)   (/ μ l) 
Cremaster venules in  
  trauma-induced infl  ammation
ST3Gal-IV       /     13 58 30   ±   1 2,800   ±   200 2,400   ±   200 5,500   ±   600
WT 13 37 32   ±   1 3,100   ±   200 2,500   ±   200 5,600   ±   800
n.s. n.s. n.s. n.s.
Chemokine-treated cremaster venules  
  in trauma-induced infl  ammation
ST3Gal-IV      /     10 19 31   ±   1 2,000   ±   200 1,700   ±   100 5,700   ±   700
CXCR2  bm    /     55 3 1    ±   3 1,600   ±   100 1,500   ±   300 4,800   ±   100
WT 19 30 30   ±   1 2,300   ±   200 1,900   ±   200 6,300   ±   500
n.s. n.s. n.s. n.s.
Cremaster venules in  
  TNF-      –  induced infl  ammation
ST3Gal-IV      /     16 90 30   ±   1 2,300   ±   100 1,900   ±   100 3,400   ±   500
CXCR2  bm    /     8 76 31   ±   1 1,800   ±   110 1,500   ±   120 2,600   ±   200
WT 16 67 32   ±   1 2,100   ±   100 1,700   ±   100 2,800   ±   400
n.s. n.s. n.s. n.s.
n.s., nonsignifi  cant (P   >   0.05).JEM VOL. 205, June 9, 2008 
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toxin (PTx), an inhibitor of G      i   protein  –  coupled receptors, 
3 h before cremaster muscle exteriorization. Similar to a 
previous report (  5  ), PTx pretreatment of WT control mice 
led to a signifi  cant attenuation in the increase of adherent 
leukocytes after CXCL1 injection (83   ±   21 cells/mm  2  ) 
when compared with WT control mice without PTx (  Fig. 
1 B  ). Similar results were obtained in PTx-pretreated con-
trol mice after injection of CXCL8 (88   ±   33 cells/mm  2  ). 
In ST3Gal-IV      /      mice, no signifi  cant  infl   uence of PTx 
pretreatment was noted on the number of accumulated 
leukocytes after CXCL1 or CXCL8 injection (45   ±   27 and 
88   ±   40 cells/mm  2  , respectively;   Fig. 1 B  ), suggesting that 
leukocyte adhesion triggered by CXCR2 is signifi  cantly 
impaired in ST3Gal-IV      /      mice. Finally, we investigated 
the increase in the number of adherent leukocytes in cre-
master muscle venules of CXCR2  bm    /      mice after systemic 
injection of CXCL1 or CXCL8. Similar to ST3Gal-IV      /      
mice, leukocyte adhesion after CXCL1 increased only by 
80   ±   16 and 88   ±   41 cells/mm  2   after CXCL8 (  Fig. 1 B  ). 
This was signifi  cantly diff  erent to the results observed in 
WT mice, demonstrating that CXCR2 is crucial in medi-
ating CXCL1/CXCL8-dependent leukocyte adhesion in 
this setting. 
of the cremaster muscle was signifi  cantly lower in ST3Gal-
IV      /      than in WT control mice, suggesting a defect in fi  rm 
leukocyte arrest in ST3Gal-IV      /      mice (  Fig. 1 A  ). As re-
cently demonstrated, leukocyte adhesion in untreated cre-
master muscle venules is mediated via interactions between 
chemokine receptor CXCR2 expressed on the surface of 
rolling neutrophils and endothelial-bound chemokines, in-
cluding keratinocyte-derived chemokine (CXCL1) (  5  ). We 
analyzed leukocyte adhesion in untreated mice before and 
3 min after systemic injection of 600 ng CXCL1 or the hu-
man prototype CXC chemokine CXCL8 (600 ng/mouse). 
Microvascular parameters during those experiments were 
similar between the groups (  Table I  ). In WT mice, the 
number of adherent leukocytes increased by 457   ±   83 cells/
mm  2   after CXCL1 injection and by 422   ±   87 cells/mm  2   
after CXCL8 (  Fig. 1 B  ; and Video 1, available at http://www
.jem.org/cgi/content/full/jem.20070846/DC1). In contrast, 
leukocyte adhesion in ST3Gal-IV      /      mice increased only 
by 73   ±   17 cells/mm  2   after CXCL1 injection and by 73   ±   
34 cells/mm  2   after CXCL8 injection (  Fig. 1 B  ; and Video 2), 
suggesting that CXCL1- and CXCL8-induced fi  rm adhe-
sion are dependent on ST3Gal-IV. Next, leukocyte adhe-
sion was investigated in mice pretreated with 4   μ  g pertussis 
    Figure 1.         Leukocyte adhesion during infl  ammation in vivo.   (A) Number of adherent leukocytes (mean   ±   SEM per mm  2   of surface area) in unstimu-
lated mouse cremaster muscle venules of WT control and ST3Gal-IV     /     mice. (B) Increase in the number of adherent leukocytes (mean   ±   SEM per mm  2   of 
surface area) 3 min after systemic injection of 600 ng CXCL1 or CXCL8 in WT control, ST3Gal-IV     /    , WT control (plus 4   μ  g PTx), ST3Gal-IV     /     (plus  4   μ g 
PTx), and CXCR2  bm   /     mice. PTx was injected 3 h before cremaster muscle exteriorization. (C) Leukocyte adhesion (mean   ±   SEM) was observed in 3-h 
TNF-      –  treated cremaster muscle venules of WT control, ST3Gal-IV     /    , and CXCR2  bm   /     mice. Additionally, pretreatment of TNF-    – treated  WT  control, 
ST3Gal-IV     /    , and CXCR2  bm   /     mice was conducted with 4   μ  g PTx and/or 100   μ  g E-selectin mAb 9A9 5 min before TNF-     injection. Data in A  –  C were 
obtained from at least three independent experiments per group. *, P   <   0.05 versus WT control mice (A and C); *, P   <   0.05 versus WT control mice treated 
with CXCL1 or CXCL8, respectively (B). Videos 1 and 2 are available at http://www.jem.org/cgi/content/full/jem.20070846/DC1.     1438 ST3  GAL  -IV CONTROLS LEUKOCYTE ADHESION   | Frommhold et al. 
was similar between WT (674   ±   80 cells/mm  2  ), ST3Gal-
IV      /      (759   ±   66 cells/mm  2  ), and CXCR2  bm    /      (717   ±   68 
cells/mm  2  ) mice (  Fig. 1 C  ). In agreement with a previous 
study, pretreatment with the E-selectin blocking mAb 9A9 or 
PTx did not aff  ect neutrophil arrest in WT control mice 
(799   ±   128 and 823   ±   91 cells/mm  2  , respectively;   Fig. 1 C  ) (  5  ). 
Similarly, ST3Gal-IV      /      or CXCR2  bm    /      mice pretreated 
with PTx revealed no changes in neutrophil arrest (821   ±   78 
and 686   ±   47 cells/mm  2  , respectively) compared with WT 
control mice. In contrast, ST3Gal-IV      /      or CXCR2  bm    /      
mice pretreated with E-selectin blocking mAb 9A9 showed 
signifi  cantly reduced leukocyte adhesion (308   ±   56 and 239   ±   
31 cells/mm  2  , respectively; P   <   0.05 vs. WT control;   Fig. 1 C  ) 
when compared with WT control mice, suggesting that leu-
kocyte arrest triggered by CXCR2 is considerably aff  ected in 
ST3Gal-IV      /      mice. This was also supported by experiments 
in ST3Gal-IV      /      and CXCR2  bm    /      mice pretreated with 
both PTx and E-selectin blocking mAb 9A9, where leukocyte 
adhesion was not further reduced (324   ±   45 and 295   ±   30 
cells/mm  2  , respectively;   Fig. 1 C  ). In addition, in WT control 
mice pretreated with PTx and E-selectin blocking mAb 9A9, 
leukocyte adhesion was also signifi  cantly decreased (304   ±   54 
cells/mm  2  ;   Fig. 1 C  ), confi  rming the crucial role of ST3Gal-
IV for fi  rm leukocyte adhesion in vivo. 
  To exclude the possibility that a reduction in leukocyte 
rolling is responsible for the impaired fi  rm leukocyte arrest 
observed in ST3Gal-IV      /      and CXCR2  bm    /      mice, we as-
sessed leukocyte rolling in unstimulated cremaster muscle ven-
ules of WT control, ST3Gal-IV      /     , and CXCR2  bm    /      mice. 
We found a signifi  cant increase in the leukocyte rolling fl  ux 
fraction in ST3Gal-IV      /      (46   ±   5%) and CXCR2  bm    /      (51   ±   
7%) mice compared with control mice (32   ±   4%; P   <   0.05; 
Fig. S1 A, available at http://www.jem.org/cgi/content/full/
jem.20070846/DC1), refl  ecting the inability of ST3Gal-IV      /      
and CXCR2  bm    /      leukocytes to transit from established roll-
ing into fi  rm arrest. 
  Leukocyte adhesion in TNF-      –  induced infl  ammation 
  Next, we observed leukocyte adhesion in 90 TNF-      –  treated 
(3 h) cremaster muscle venules of 16 ST3Gal-IV      /      mice and 
in 76 venules of 8 CXCR2  bm    /      mice, and compared it with 
leukocyte adhesion in 67 venules of 16 WT animals. In this 
model, transition from leukocyte rolling to fi  rm adhesion after 
TNF-     pretreatment is mediated in an overlapping fashion 
involving CXCR2 and E-selectin (  5  ). Microvascular parame-
ters for the groups are presented in   Table I   and show similar 
vessel diameters, centerline velocities, wall shear rates, and 
WBC counts. Leukocyte adhesion 3 h after TNF-     treatment 
    Figure 2.         Cremaster muscle whole mount.   Giemsa-stained whole-mounts of TNF-      –  treated cremaster muscles of WT, ST3Gal-IV     /    , and CXCR2  bm   /    
mice were analyzed for the number of intravascular (A) and perivascular (B) leukocytes (mean   ±   SEM per mm  2   surface area). In addition, two typical 
micrographs are presented illustrating intra- and perivascular leukocyte distribution in TNF-      –  treated cremaster muscle whole mounts of WT control 
mice (C) and ST3Gal-IV     /     mice pretreated with E-selectin blocking mAb 9A9 (D). Data in A and B were obtained from at least three independent experiments 
per group. *, P   <   0.05 versus WT mice. Bars, 50   μ  m.     JEM VOL. 205, June 9, 2008 
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of thioglycollate (  5  ). We investigated neutrophil infl  ux into 
the peritoneum of WT, ST3Gal4      /     , and CXCR2  bm    /      
mice 4 h after thioglycollate injection. Neutrophil recruit-
ment to the peritoneum was signifi  cantly reduced to 60% in 
ST3GalIV      /      mice (4.5   ×   10  6   cells;   n   = 9;   Fig. 3  ), to 57% in 
WT mice pretreated with PTx (4.3   ×   10  6   cells;   n   = 6), and to 
35% in CXCR2  bm    /      mice (2.5   ×   10  6   cells;   n   = 3) when 
compared with WT mice (7.5   ×   10  6   cells;   n   = 7; P   <   0.05). 
These results suggest that chemokine-triggered signaling is 
impaired in ST3Gal-IV      /      mice, which was also confi  rmed 
by the observation that pretreatment of ST3Gal-IV      /      mice 
with PTx did not cause a further signifi  cant reduction in neu-
trophil extravasation after thioglycollate injection (2.7   ×   10  6   
cells;   n   = 5;   Fig. 3  ). 
  Ligand binding and functional activity of CXCR2 
on ST3Gal-IV      /      neutrophils 
  Because CXCR2 was found to carry several   N  -glycosylation 
sites with potential terminal sialylation (  9  ), we tested whether 
defi  ciency of ST3Gal-IV would directly aff  ect the biology of 
this receptor. To address the possibility that a lower expres-
sion of CXCR2 on ST3Gal-IV      /      leukocytes contributes to 
the decrease in the number of adherent leukocytes, we ini-
tially performed fl  ow cytometric analysis of CXCR2 expres-
sion on GR-1  –  positive leukocytes of ST3Gal-IV      /      and 
WT control mice (  Fig. 4 A  ). CXCR2 expression was slightly 
higher in ST3Gal-IV      /      compared with WT control mice, ex-
cluding a lower expression of CXCR2 in ST3Gal-IV      /      mice 
to be responsible for the observed defect in leukocyte adhe-
sion in these mice. We then questioned whether ST3Gal-IV 
defi  ciency would aff  ect ligand binding to CXCR2. For the 
ligand binding assays, we chose to use human carboxyfl  uo-
rescein-labeled CXCL8 (CF-CXCL8), because bound CF-
CXCL8 can be directly detected by fl  ow cytometric analysis 
of leukocyte populations within mouse blood. Human CXCL8 
  Next, we assessed leukocyte rolling in WT, ST3Gal-
IV      /     , and CXCR2  bm    /      mice. We found no diff  erence in 
the leukocyte rolling fl  ux fraction in TNF-      –  stimulated 
cremaster muscle venules of ST3Gal-IV      /      (21   ±   4%) and 
CXCR2  bm    /      (15   ±   2%) mice compared with WT control 
mice (20   ±   3%; Fig. S1 B). 
  Leukocyte adhesion and extravasation in whole mounts 
of TNF-      –  treated cremaster muscles 
  To investigate the contribution of ST3Gal-IV on the com-
position and number of extravasated neutrophils, we per-
formed Giemsa staining of whole-mount cremaster muscles 
pretreated with TNF-     and classifi  ed leukocytes into neutro-
phils, eosinophils, and mononuclear cells. In ST3Gal-IV      /      
and CXCR2  bm    /      mice, the number of intravascular and 
extravasated neutrophils was similar to that observed in WT 
mice (  Fig. 2, A  –  C  ). Relative frequencies of intravascular and 
extravasated neutrophils, mononuclear cells, and eosinophils 
were comparable between ST3Gal-IV      /      and WT mice, 
suggesting that leukocyte recruitment in ST3Gal-IV      /      mice 
is not impaired after stimulation with TNF-     (unpublished 
data). Pretreatment of ST3Gal-IV      /      or CXCR2  bm    /      mice 
with the G      I   blocker PTx did not signifi  cantly infl  uence the 
number of intra- and extravascular leukocytes nor the relative 
leukocyte frequencies (  Fig. 2  ; unpublished data). 
  Next, we investigated the number of intra- and perivas-
cular neutrophils in TNF-      –  stimulated cremaster muscle 
venules of ST3Gal-IV      /      and WT control mice pretreated 
with the E-selectin blocking mAb 9A9. Blocking E-selectin in 
WT control mice did not change the number of intravascular 
neutrophils nor neutrophil extravasation when compared with 
untreated WT control mice (  Fig. 2, A and B  ). In addition, 
the composition of perivascular leukocytes was similar between 
E-selectin mAb 9A9  –  pretreated WT control mice and un-
treated WT control mice (unpublished data). In ST3Gal-IV      /      
mice pretreated with the E-selectin blocking mAb 9A9, 
intravascular as well as perivascular neutrophils were signifi  -
cantly decreased compared with WT control mice ( Fig. 2, A –  D  ). 
However, the composition of extravasated leukocytes in 
E-selectin blocking mAb 9A9  –  pretreated ST3Gal-IV      /      mice 
did not signifi  cantly change compared with WT mice, suggest-
ing that the emigration of mononuclear cells and eosinophils 
was also impaired (unpublished data). Next, we investigated 
intra- and perivascular neutrophils in WT control and CX-
CR2  bm    /      mice pretreated with the E-selectin blocking mAb 
9A9 and PTx (  Fig. 2, A and B  ). We found a similar reduction 
in the number of perivascular neutrophils as in E-selectin 
blocking mAb 9A9  –  pretreated ST3Gal-IV      /      mice, confi  rm-
ing that ST3Gal-IV is involved in CXCR2-dependent extrav-
asation of neutrophils. 
  Thioglycollate-induced peritonitis 
  As reported previously, neutrophil arrest inhibition through 
blockade of G      i   protein  –  coupled receptor (GPCR)  –  depen-
dent signals leads to impaired extravasation of neutrophils into 
the infl  amed peritoneal cavity after intraperitoneal injection 
    Figure 3.         Thioglycollate-induced peritonitis.   Peritoneal  neutrophil 
infl  ux was assessed 4 h after injection of 4% thioglycollate into WT (  n   = 
7), ST3Gal-IV     /     ( n   = 9), WT (plus 4   μ  g PTx;   n   = 6), ST3Gal-IV     /     (plus  4 
 μ g  PTx;   n   = 5), and CXCR2  bm   /     ( n   = 3) mice. The number of neutrophils 
( × 10 6  ; mean   ±   SEM) was assessed from Turks-stained peritoneal lavage 
samples. *, P   <   0.05 versus WT control mice.     1440 ST3  GAL  -IV CONTROLS LEUKOCYTE ADHESION   | Frommhold et al. 
  Leukocyte adhesion in ST3Gal-IV      /      neutrophils 
in the microfl  ow chamber assay 
  Next, we investigated the role of ST3Gal-IV on leukocyte 
arrest using a recently described autoperfused microfl  ow 
chamber system coated with recombinant mouse P-selectin, 
inter  cellular adhesion molecule 1 (ICAM-1), and CXCL1 (  15  ). 
This combination of proteins mediates rolling and fi  rm arrest of 
WT neutrophils (  15  ). Rolling of WT and ST3Gal-IV      /      leuko-
cytes was noted in all fl  ow chambers in which P-selectin was 
immobilized (  Fig. 5 A  ). However, a marked reduction in the 
rolling of control leukocytes was noted in the presence of 
ICAM-1 and CXCL1, which was most likely caused by the 
concomitant signifi  cant increase in the number of adherent 
leukocytes (  Fig. 5 A  ). As depicted in   Fig. 5 B  , adhesion of WT 
leukocytes was only observed in fl  ow chambers in which all 
three molecules (P-selectin, ICAM-1, and CXCL1) were im-
mobilized. Leukocytes from ST3Gal-IV      /      mice also fi  rmly ad-
hered only in those fl  ow chambers in which P-selectin, ICAM-1, 
and CXCL1 were immobilized on the surface. However, the 
number of adherent leukocytes was signifi  cantly lower than 
observed with control leukocytes under the same conditions 
(  Fig. 5 B  ). These results strongly suggest that ST3Gal-IV sig-
nifi  cantly contributes to the successful arrest of leukocytes in the 
presence of CXCL1, ICAM-1, and P-selectin. 
  Transendothelial migration of neutrophils 
  To study the contribution of neutrophil-expressed ST3Gal-
IV on neutrophil transmigration, CXCL1-triggered trans-
endothelial migration of ST3Gal-IV      /      neutrophils through 
an endothelial cell line monolayer (b.End5) was investigated. 
As depicted in   Fig. 5 C  , transendothelial migration was 
signifi  cantly reduced for ST3GalIV      /      compared with WT 
neutrophils. In addition, transendothelial migration of neur-
aminidase-pretreated control neutrophils was also mark-
edly impaired (  Fig. 5 C  ), suggesting that     2,3 sialylation by 
ST3Gal-IV is important for CXCL1-induced neutrophil 
transmigration. Pretreatment of the endothelial cell line b.
End5 with neuraminidase before addition of WT neutro-
phils did not reduce the number of migrated neutrophils, sug-
gesting that the impairment in neutrophil recruitment seen 
in ST3Gal-IV      /      mice is caused by the loss of crucial     2,3-
linked sialic acid residues on neutrophils, not on endothelial 
cells (  Fig. 5 C  ). To rule out any signifi  cant eff  ect of CXCL1-
independent transmigration, we also performed transmigra-
tion experiments without CXCL1. Spontaneous neutrophil 
transmigration (without CXCL1) was similar for WT and 
ST3Gal-IV      /      neutrophils (0.07   ±   0.04   ×   10  6   vs. 0.06   ±   
0.01   ×   10  6   cells, respectively) and accounted for 20 and 
17% of migrated neutrophils, respectively, compared with 
the total number of migrated WT neutrophils observed during 
CXCL1-induced transmigration (unpublished data). 
  Effect of enzymatic desialylation on the binding 
and activity of CXCR2 on human neutrophils 
  Biochemical studies on the presence of terminal sialic acids 
on CXCR2 were performed with human CXCR2, which 
binds with high affi   nity to mouse CXCR2 (  14  ) and exerts 
the same in vivo eff  ect as CXCL1 when injected into WT 
cremaster muscle venules (  Fig. 1 B   and Video 1). Human 
CXCL8 can therefore be used for binding studies in mouse 
neutrophils. The specifi   city of CF-CXCL8 binding was 
demonstrated by its decreased binding to neutrophils from 
CXCR2  bm    /      mice (  Fig. 4 B  ) When compared with WT 
leukocytes, leukocytes from ST3Gal-IV      /      mice showed a 
considerably reduced ability to bind CF-CXCL8. A reduc-
tion in CF-CXCL8 binding was also observed when WT 
neutrophils were treated with neuraminidase, which removes 
terminal sialic acids from surface glycoproteins. These data 
point toward a role of     2,3-linked sialic acid residues for effi   -
cient binding of CXCR2 ligands to mouse neutrophils. 
    Figure 4.         CXCR2 expression and ligand binding of ST3Gal-IV      /      
leukocytes.   (A) Surface expression of CXCR2 on GR-1  –  positive leukocytes 
of ST3Gal-IV     /     and WT mice was analyzed by fl  ow cytometry. Leukocytes 
were incubated with an allophycocyanin-labeled GR-1 mAb, a PE-labeled 
anti-CXCR2 mAb, and a PE-labeled isotype control. (B) For ligand binding 
studies, leukocytes from the peripheral blood of WT (  n   = 4), ST3Gal-IV     /    
(  n   = 3), and CXCR2  bm   /     ( n   = 3) mice were incubated with different dilu-
tions of CF-CXCL8 and subsequently analyzed for bound fl  uorescence by 
fl  ow cytometry. Peripheral blood leukocytes from WT mice were treated 
with 100 mU/ml neuraminidase for 60 min and investigated for CF-CXCL8 
binding. Data are given as mean   ±   SD. P   <   0.05 for WT versus ST3Gal-
IV     /   ,  CXCR2 bm   /    , and WT + Neu for 30 and 90 nM CF-CXCL8, respec-
tively. MFI, mean fl   uorescence  intensity.   JEM VOL. 205, June 9, 2008 
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chemokine to neutrophils (  Fig. 6 B  ). For these experiments, 
CXCL7 was chosen as a radioligand, because this chemo-
kine displays high affi   nity binding to CXCR2 and low af-
fi  nity binding to CXCR1, whereas CXCL8 binds to both 
CXCR1 and CXCR2 with high affi   nity (  17  ). Scatchard plot 
analysis revealed that CXCL7 binding to high affi   nity sites 
was shifted from 6.6 to 20 nM after neuraminidase treatment, 
whereas the low affi   nity binding was not aff  ected (  Fig. 6 C  ). 
The total number of binding sites was not changed upon 
treatment with neuraminidase, which was consistent with 
the unaff  ected expression level of CXCR2 and CXCR1 on 
the surface of these cells, as determined by fl  ow cytometry 
(Fig. S2 A, available at http://www.jem.org/cgi/content/full/
jem.20070846/DC1). Binding of platelet factor 4 (CXCL4), 
which is not dependent on either of the two receptors 
(CXCR1 or CXCR2), was not aff  ected by neuraminidase 
treatment (  Fig. 6 B  ). 
  Functionally, CXCL7 and CXCL8 induce lysosomal 
degranulation of neutrophils. We investigated the release of elas-
tase from primary granules of CXCL8- and CXCL7-treated 
neutrophils and found that elastase release was considerably 
could be precipitated from CXCR2-transfected HEK293 
cells and subsequently probed for the binding of the   Maackia 
amurensis   lectin II (MAL-II), which preferentially recognizes 
carbohydrate chains containing sialic acid residues    2,3 linked 
to penultimate galactose residues (  16  ). Digestion of precipi-
tates with neuraminidase clearly abolished MAL-II binding 
but not detection of CXCR2, indicating that CXCR2 car-
ries terminal sialic acids (  Fig. 6 A  ). In addition, binding of 
CF-CXCL8 to HEK293 cells was clearly dependent on the 
presence of CXCR2, because CF-CXCL8 did not bind to 
untransfected HEK293 cells (unpublished data). However, as 
seen for mouse neutrophils (compare with   Fig. 4 B  ), binding 
was considerably reduced (by 46%; not depicted) when the 
cells were desialylated by treatment with neuraminidase. 
  To address whether terminal sialylation is also implicated 
in the ligand binding and function of CXCR2 on human 
neutrophils, isolated human neutrophils were treated with 
diff  erent dosages of neuraminidase. As demonstrated by bind-
ing assays with the radioactively labeled CXCR2 ligand 
  125  I-labeled neutrophil-activating peptide 2 (CXCL7), treat-
ment with neuraminidase resulted in reduced binding of the 
    Figure 5.         Adhesion in the fl  ow chamber and transmigration of ST3Gal-IV      /      neutrophils in vitro.   The number of rolling and adherent leuko-
cytes from ST3Gal-IV     /     and WT mice was determined in blood-perfused microfl  ow chambers. (A) Rolling and (B) adherent leukocytes in autoperfused 
fl  ow chambers (5.94 dynes/cm  2  ) coated with 20   μ  g/ml P-selectin and 15   μ  g/ml ICAM-1 with or without 15   μ  g/ml CXCL1. Data in A and B are presented as 
mean   ±   SEM from at least four mice and four fl  ow chambers. *, P   <   0.05 versus WT mice (B). (C) The percentage of transmigrated neutrophils from WT 
control mice, ST3Gal-IV     /     mice, and WT control mice pretreated with neuraminidase was assessed in a transwell assay in which transwells were coated 
with an immortalized endothelial cell line, b.End5. In addition, transmigration of WT control neutrophils through a neuraminidase-pretreated b.End5 
monolayer was analyzed. Data in C were determined from at least three independent experiments per group. *, P   <   0.05 versus untreated WT control neu-
trophils (C). FOV, fi  eld of view.     1442 ST3  GAL  -IV CONTROLS LEUKOCYTE ADHESION   | Frommhold et al. 
    DISCUSSION   
  Chemokine receptors and their ligands are involved in many 
immunological processes requiring specifi  c and high affi   nity 
interactions between chemokine receptors and their respec-
tive ligands (  18  –  21  ). Specifi  city is in part achieved by post-
translational modifi  cation of chemokine receptors, as recently 
demonstrated for CXCR2 and CCR5 (  9, 10  ). 
  The chemokine receptor CXCR2 (mouse homologue of 
IL-8 receptor B) is involved in chemokine-induced leuko-
cyte adhesion and migration (  22  –  24  ). Two studies identifi  ed 
CXCR2 as playing a critical role during the pathogenesis of 
ventilator- or LPS-induced infl  ammatory lung injury (  25, 26  ). 
In addition, CXCR2 was also shown to participate in the 
recruitment of macrophages into established atherosclerotic 
lesions (  27  ). 
  In contrast to the variety of publications illustrating 
CXCR2-mediated eff  ects in a wide spectrum of diseases, lit-
tle is known about how CXCR2 achieves specifi  c binding to 
its ligands. We present for the fi  rst time in vivo evidence that 
reduced when human neutrophils were pretreated with 
neuraminidase (  Fig. 6 D  ). Notably, elastase release in re-
sponse to the preferential CXCR2 ligand CXCL7 was 
more profoundly reduced than that after CXCL8 stimula-
tion, which is explained by the fact that CXCL8 binds and 
functions via both CXCR1 and CXCR2 (  17  ). Importantly, 
enzymatic digestion did not lead to a decreased reactivity of 
neutrophils in general, as stimulation with the tripeptide 
  N  -formyl-Met-Leu-Phe (fMLP) induced similar responses 
in untreated and enzyme-treated neutrophils (  Fig. 6 D  ). 
These fi   ndings were further corroborated by measuring 
CXCL7-induced lactoferrin release from secondary granules, 
which was signifi  cantly diminished in neuraminidase-treated 
neutrophils (Fig. S2 B). In contrast, lactoferrin release trig-
gered by CXCL4 (which does not bind to CXCR2) was 
not infl   uenced by the enzymatic treatment (Fig. S2 B). 
Thus, terminal sialic acids are found on CXCR2, and defi  cient 
sialylation in neutrophils decreases ligand binding and activ-
ity of the receptor. 
    Figure 6. Effect of enzymatic desialylation on chemokine binding and function of human CXCR2.   (A) Cell lysates of CXCR2-transfected and un-
transfected HEK293 cells were incubated with an mAb to CXCR2, followed by precipitation with protein A. Precipitates were treated with 20 U/ml neur-
aminidase for 60 min at 37  °  C, or were left untreated and analyzed by Western blotting for binding of biotinylated anti-CXCR2 antibody or biotinylated 
MAL-II, respectively. (B) Isolated human neutrophils were treated with the indicated dosages of neuraminidase for 30 min at 37  °  C, washed, and subse-
quently assayed for binding of   125  I-labeled CXCL7 and   125  I-labeled CXCL4. Specifi  cally bound radioactivity was expressed as the percentage of WT con-
trol cells receiving no enzyme treatment. (C) Scatchard plot for CXCL7 binding to untreated and neuraminidase-treated (20 U/ml) human neutrophils. 
The binding data were curve fi  t to determine affi  nity constants for high and low affi  nity binding sites. (D) Neutrophils were treated with the indicated 
dosages of neuraminidase for 30 min at 37  °  C, washed, and subsequently assayed for elastase release in response to increasing concentrations of CXCL7, 
CXCL8, and fMLP. The residual responsiveness of neuraminidase-treated neutrophils was expressed as the percentage of that determined for untreated 
cells. Data in A  –  D represent means   ±   SD determined in three different experiments, each with blood from a different donor.    JEM VOL. 205, June 9, 2008 
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that enzymatic removal of terminal sialic acids results in re-
duced CXCR2 ligand binding to human neutrophils. When 
using   125  I-labeled CXCL7 as a high affi   nity CXCR2 ligand 
for binding studies with human neutrophils, we found a 
strong reduction in the affi   nity of CXCR2 when neutrophils 
were treated with neuraminidase, as shown by Scatchard 
analysis of the binding kinetics. In contrast, neuraminidase 
treatment of neutrophils neither aff  ected the number of bind-
ing sites nor the expression level of CXCR2. These data 
suggest that sialic acids on neutrophils are required to main-
tain high ligand binding affinity rather than surface ex-
pression of the receptor. Although defective sialylation of 
CXCR2 in ST3Gal-IV      /      mice could not be directly dem-
onstrated at the molecular level, we were able to demon-
strate that human CXCR2 carries terminal sialic acids, which 
were sensitive to neuraminidase treatment. As a consequence 
of reduced receptor interaction, we observed decreased ad-
hesion, transmigration, and degranulation of mouse or hu-
man leukocytes in response to CXCR2 ligands. To confi  rm 
that glycosylation defects would not aff  ect the responsiveness 
of neutrophils in general, we stimulated neutrophils inde-
pendent of CXCR2 using fMLP and CXCL4. Treatment 
with those proinfl  ammatory mediators did not alter neutro-
phil responsiveness after desialylation. This does not exclude 
a requirement for terminal sialic acids for ligand binding by 
other chemokine receptors such as CCR5, for which an im-
portant role of glycosylation has also been demonstrated (  10  ). 
However, CCR7-dependent migration of dendritic cells 
was not aff  ected in ST3Gal-IV      /      mice (unpublished data), 
suggesting that sialylation cannot be considered a general re-
quirement for optimal chemokine receptor  –  mediated events. 
Accordingly, our results suggest that posttranslational sialylation 
may be a new regulatory mechanism by which chemokine-
triggered recruitment of some leukocyte subpopulations 
may occur. However, at present it remains unclear how 
cell type  –  specifi  c expression of the diff  erent sialyltransfer-
ases contributes to chemokine receptor  –  mediated leukocyte 
adhesion. For the ST3Gal family of sialyltransferases, six dif-
ferent isoenzymes have been described (  28  ). Previous studies 
of ST3Gal sialyltransferases have revealed diff  erent sub-
strate specifi  city and tissue expression of the various isoen-
zymes (  29  ). ST3Gal-IV shares substrate specifi  city mostly 
with ST3Gal-VI and, to a minor degree, with ST3Gal-III. 
This may indicate that ST3Gal-VI (besides ST3Gal-IV) 
could also be involved in the regulation of chemokine 
receptor  –  triggered leukocyte arrest. Currently, ST3Gal-VI      /      
mice are not available. Future studies using ST3Gal-VI      /      
mice and ST3Gal-IV      /     /ST3Gal-VI      /      mice will help to 
further characterize the role of sialylation on chemokine 
receptor function. 
  Collectively, our fi  ndings provide novel evidence for a 
crucial role of the sialyltransferase ST3Gal-IV in CXCR2-
mediated neutrophil adhesion and recruitment under infl  am-
matory conditions. Besides initiating the development of new 
therapeutic strategies in the treatment of CXCR2-mediated 
diseases, these results should also serve in stimulating additional 
CXCR2-triggered leukocyte arrest during infl  ammation is 
strongly dependent on posttranslational sialylation mediated 
by ST3Gal-IV. This can be deduced from results in ST3Gal-
IV      /      mice, where baseline as well as CXCL1- or CXCL8-
triggered leukocyte adhesion in trauma-induced infl  ammation 
was signifi  cantly lower than in WT control mice. However, 
leukocyte adhesion was comparable to either WT control 
and ST3Gal-IV      /      mice pretreated with PTx, an inhibitor of 
GPCRs, or CXCR2  bm    /      mice, suggesting an important 
role for     2,3-sialylation in CXCR2 function in vivo. In a 
second approach, we found that leukocyte adhesion in TNF-
      –  stimulated cremaster muscle venules was similar between 
ST3Gal-IV      /     , CXCR2  bm    /     , and WT control mice. In this 
model, leukocyte adhesion occurs in an overlapping fashion by 
E-selectin  –   and chemokine-triggered CXCR2 activation (  5  ). 
Although blockade of GPCRs with PTx did not have any 
eff  ect on leukocyte adhesion in ST3Gal-IV      /     , CXCR2  bm    /     , 
or WT mice, pretreatment of ST3Gal-IV      /      and CXCR2  bm    /      
mice but not WT mice with E-selectin blocking mAb 9A9 
led to a signifi  cant reduction of leukocyte adhesion, sug-
gesting that CXCR2-triggered fi  rm arrest is defective in 
ST3Gal-IV      /      mice. 
  To challenge our results and directly investigate CXCR2-
dependent leukocyte adhesion in a more reductionist system 
in which all   “  endothelial players  ”   are known, we used a re-
cently described ex vivo fl  ow chamber system and coated the 
surface of the rectangular fl  ow chamber with recombinant 
mouse P-selectin, ICAM-1, and CXCL1 (  15  ). Although we 
observed some adhesion of ST3Gal-IV      /      leukocytes in the 
fl  ow chamber, the number of adherent cells was signifi  cantly 
lower than that seen in control mice. These data strongly 
support the hypothesis that CXCR2-mediated events leading 
to fi  rm leukocyte arrest are impaired in ST3Gal-IV      /      mice. 
In addition, the results suggest that the adhesion defect is lo-
cated on neutrophils. This observation was confi  rmed and 
expanded into the human system in direct ligand binding 
assays using fl  uorescently labeled CXCL8 and radiolabeled 
CXCL7. We found a signifi  cant and dose-dependent reduc-
tion in the binding of CF-CXCL8 to ST3Gal-IV      /      neutro-
phils when compared with control neutrophils. In addition, 
we observed a strong reduction in   125  I-labeled CXCL7 bind-
ing to neuraminidase-pretreated human neutrophils. Re-
cently, Reutershan et al. identifi  ed a critical role for endothelial 
CXCR2 in the successful migration of neutrophils into LPS-
stimulated lung tissue (  26  ). We have not formally ruled out a 
role for endothelial CXCR2 in leukocyte adhesion and mi-
gration in stimulated cremaster muscle venules in vivo. How-
ever, we did not detect an eff  ect of endothelial CXCR2 in 
mediating neutrophil transmigration in the chemotaxis assay 
using the brain endothelial cell line b.End5, suggesting that 
various endothelial compartments may diff  er in their ability 
to express functional CXCR2. 
  In a previous study, we reported that human CXCR2 is 
  N  -glycosylated at two distinct sites. This was shown by en-
zymatic deglycosylation and Western blotting of the immu-
noprecipitated receptor (  9  ). In this study, we demonstrate 1444 ST3  GAL  -IV CONTROLS LEUKOCYTE ADHESION   | Frommhold et al. 
gation and red blood cell lysis with PharM-Lyse 10  ×   solution (BD Biosci-
ences), cells were suspended in PBS/1% BSA solution and incubated in the dark 
with a PE-conjugated mAb against CXCR2, an allophycocyanin-conjugated 
mAb against GR-1, and appropriate rat isotype controls (0.5   μ  g per 10  6   cells; 
Becton Dickinson) for 30 min on ice. To study binding of CXCL8, blood 
leukocytes were incubated with diff  erent concentrations of CF-CXCL8 in 
the absence or presence of a 10-fold excess of unlabeled CXCL8 in PBS/1% 
BSA for 30 min on ice. Gated neutrophil populations were analyzed using a 
FACSCalibur or LSR II (both from BD Biosciences) with the FACSDiva 
software package (BD Biosciences). 
  Transendothelial migration assay.     Transendothelial migration of neutro-
phils was analyzed as previously described (  35  ). In brief, 5   ×   10  5   bone marrow  –
  isolated neutrophils were added on top of a bEnd.5 cell monolayer that had 
been grown for 2 d in transwells (5   ×   10  4   bEnd.5 cells per well; Costar) with 
a 5-  μ  m pore size, coated with 50   μ  g/ml laminin (Boehringer Mannheim). 16 
h before adding neutrophils, bEnd.5 cells were stimulated with 5 nM TNF-
    . Assays were run at 37  °  C and 10% CO  2   for 30 min in presence of 40 ng/ml 
CXCL1 in the bottom chamber. Migrated neutrophils were collected for cell 
counting (CASY; Sch  ä  rfe-System). In some experiments, WT control neu-
trophils were incubated with 0.1 U neuraminidase from   Arthrobacter ureafaciens   
(Roche) per 10  6   cells at 37  °  C for 20 min. 
  Enzymatic deglycosylation.     Isolated human neutrophils of CXCR2-
transfected HEK293 cells were suspended at 10  7   cells/ml in PBS containing 
0.1% BSA and treated with the indicated dosages of recombinant N-glycosidase 
F or purifi  ed neuraminidase from   Vibrio cholerae   (both from Roche) for the 
indicated times. Subsequently, washed cells were investigated for radioligand 
binding and activation by chemoattractants, as described in Iodination of 
chemokines and binding assays. 
  Immunoprocipitation and Western blotting.     HEK293 cells were trans-
fected to express CXCR2 using lipofectamine (Invitrogen) and were used 
for immunoprecipitation of CXCR2, as previously described (  9  ). In brief, 
0.5   ×   10  7   cells were suspended in 1 ml of ice-cold lysis buff  er (PBS contain-
ing 1% Triton X-100 and a protease inhibitor mix; Roche) and incubated for 
10 min. Cell lysates were cleared by centrifugation at 10,000   g   for 10 min, 
and CXCR2 was precipitated with 5   μ  g/ml anti-CXCR2 antibody followed 
by the addition of 30   μ  l of protein A agarose (GE Healthcare). Washed pre-
cipitates were treated for 60 min with neuraminidase from   V. cholerae   at 37  °  C 
in PBS or left untreated. Subsequently, precipitates were analyzed by West-
ern blotting for binding of biotinylated lectin MAL-II (20   μ  g/ml) or anti-
CXCR2 antibody (2   μ  g/ml), which were detected by peroxidase-conjugated 
steptavidin (1:50,000; Roche) and addition of enhanced chemoluminescence 
substrate (GE Heathcare). 
  Iodination of chemokines and binding assays.     Chemokines were radio-
labeled by iodination at tyrosine residues using the chloramine T method (  17  ). 
Before iodination, CXCL7 was chemically modifi  ed by the introduction 
of tyrosine residues, as previously described (  17  ). PMN were suspended at 
10  7   cells/ml in Dulbecco  ’  s PBS (D-PBS)/2%BSA, and duplicate samples of 
10  6   cells were incubated on ice for 2 h with 10 nmol/liter of   125  I-labeled 
CXCL7 or 1   μ  mol/liter of   125  I-labeled CXCL4 in the presence or absence of 
a 10-fold excess of unlabeled CXCL7 or CXCL4, respectively. After twofold 
washing and sedimentation through 10% sucrose in D-PBS, bound radioac-
tivity was determined in a      counter, and unspecifi  cally bound radioactivity 
determined in the presence of the unlabeled chemokines was subtracted. 
  Degranulation assays.     Human polymorphonuclear cells from peripheral 
blood were generated as previously described (  36  ) and suspended at 10  7   
cells/ml in D-PBS/0.1% BSA (low endotoxin BSA; Serva). Before the addi-
tion of secondary stimuli, cells were incubated at 37  °  C under agitation with 
5 pg/ml cytochalasin B (Sigma-Aldrich) for the measurement of elastase re-
lease or with 9 ng/ml TNF-     for priming of lactoferrin release. Cells were 
then challenged with the secondary stimuli CXCL8 (1, 3, and 10 nM), 
studies in elucidating the role of posttranslational sialylation/
glycosylation on chemokine receptor function. 
  MATERIALS AND METHODS 
  Animals.     ST3Gal-IV      /      mice and CXCR2      /      bone marrow chimeric 
mice were generated as previously described (  12, 30  ) and housed in barrier 
facilities under specifi  c pathogen-free conditions. Animal experiments were 
approved by the Regierungspr  ä  sidium Karlsruhe (AZ 35  –  9185.81/G-67/03), 
the Bezirksregierung K  ö  ln (AZ 50.203.2 AC37, 19/04), and the University 
of Virginia Animal Care and Use Committee, 
  Reagents.     E-selectin blocking mAb 9A9 (rat IgG1; 30   μ  g per mouse) was a 
gift from B. Wolitzky (MitoKor, San Diego, CA). Mouse keratinocyte-
derived chemokine (CXCL1) and human CXCL8 were obtained from Pepro-
Tech and injected at 600 ng per mouse.   Bordetella pertussis   PTx was purchased 
from Sigma-Aldrich (4   μ  g per mouse), and rmP-selectin and rmICAM-1 
were purchased from R  &  D Systems. In certain experiments, rmTNF-     
(R  &  D Systems) was injected intrascrotally at 500 ng per mouse 3 h before in-
travital microscopy was begun. Biotinylated mAb to CXCR2 (clone RII115; 
reference   9  ) was provided by E. Brandt (Research Center Borstel, Borstel, 
Germany). Biotinylated MAL-II was obtained from Vector Laboratories. 
  Intravital microscopy.     Intravital microscopy of the cremaster muscle was 
conducted as reported previously with an upright microscope (model 
512815/20; Leica) with a saline immersion objective (SW 40/0.75NA) (  8  ). 
Experiments were recorded via a charge-coupled device camera system 
(CF8/1; Kappa) on an S-VHS recorder (Panasonic). Supplemental videos 
were generated by digitizing and compressing the appropriate video se-
quences from recorded videotapes using Final Cut 5.1 (Apple) and Premiere 
Pro 1.5 (Adobe). 
  Data analysis of intravital experiments.     Microvascular parameters were 
measured using a digital image processing system (  31  ). The rolling leukocyte 
fl  ux fraction was defi  ned as previously described (  32  ) by dividing leukocyte 
rolling fl  ux by total leukocyte fl  ux, estimated as (WBC) v  b        (d/2) (  2  ). 
(WBC) is the actual systemic leukocyte count, v  b   is the blood fl  ow velocity, 
and d is the venular diameter. 
  Whole-mount histology.     To diff  erentially count intravascular and extra-
vascular leukocytes, cremaster muscle whole mounts were prepared as previ-
ously described (  33  ). Leukocyte diff  erential counts were assessed using a 
microscope with a 100  ×   1.4NA oil immersion objective (Carl Zeiss, Inc.). 
  Thioglycollate-induced peritonitis model.     Peritoneal recruitment of 
leukocytes was induced by intraperitoneal injection of 1 ml of freshly pre-
pared thioglycollate (Sigma-Aldrich), as previously described (  33  ). Some 
mice received 4   μ  g PTx 3 h before thioglycollate injection. 4 h after thiogly-
collate injection, mice were killed, and the peritoneum was rinsed with 5 ml 
of chilled PBS and massaged for 10 s. The total neutrophil count of the peri-
toneal lavage was assessed using Turks-stained samples. 
  Ex vivo microfl  ow chamber.     Microfl  ow chambers (20   ×   200  –    μ  m cross 
section; VitroCom) were used as previously described (  15, 34  ). 20   μ  g/ml rmP-
selectin, 15   μ  g/ml rmICAM-1, and 15   μ  g/ml rmCXCL1 were immobilized 
in the chamber for 2 h at room temperature. Chambers were blocked for 1 h 
with 10% casein (Thermo Fisher Scientifi  c) and connected to tubing (PE 10; 
Becton Dickinson), which was inserted into the carotid artery. On the other 
chamber end, a tube (PE 50; Becton Dickinson) was connected and used to 
control wall shear stress. Microscopy was conducted using a microscope 
(Axioskop; Carl Zeiss, Inc.) with a saline immersion objective (SW 20/0.5NA). 
Images were recorded over 6 min for each chamber with a charge-coupled de-
vice color video camera (DXC-390; Sony) connected to an S-VHS recorder. 
  Flow cytometry.     Expression of CXCR2 was analyzed on freshly isolated 
peripheral leukocytes from control and ST3Gal-IV      /      mice. After centrifu-JEM VOL. 205, June 9, 2008 
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IV      /     , and CXCR2  bm    /      mice. Fig. S2 demonstrates the eff  ect of enzymatic 
desialylation on expression and function of CXCR2 on human neutrophils. 
Online supplemental material is available at http://www.jem.org/cgi/content/
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